把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-03-31 |
| 3/3 |
| $5.09B |
| $189M |
| — |
| 18.1% |
| 7.4% |
| 90 |
| 尚无授权文本 |
| ARTV Artiva Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$23.52M | -$21.19M | — | — | 27 | 尚无授权文本 |
| CMTV COMMUNITY BANCORP /VT | 2026-03-31 | 3/3 | — | $4.37M | $3.9M | — | — | 97 | 尚无授权文本 |
| FUBO FuboTV Inc. | 2026-03-31 | 3/3 | $1.57B | -$2.1M | -$412.98M | — | -0.6% | 115 | 尚无授权文本 |
| FVR FrontView REIT, Inc. | 2026-03-31 | 3/3 | $292,000 | $320,000 | — | — | — | 38 | 尚无授权文本 |
| MATV Mativ Holdings, Inc. | 2026-03-31 | 3/3 | $479.6M | -$11.7M | -$7.4M | 17.7% | 1.5% | 100 | 尚无授权文本 |
| MTVA MetaVia Inc. | 2026-03-31 | 3/3 | — | -$3.82M | — | — | — | 148 | 尚无授权文本 |
| OCTV Octave Intelligence plc | 2026-03-31 | 3/3 | $386.5M | $47.38M | $113.07M | 77.0% | 16.5% | 3 | 尚无授权文本 |
| PMTV PennyMac Mortgage Investment Trust | 2026-03-31 | 3/3 | — | $24.62M | — | — | — | 96 | 尚无授权文本 |
| PSTV PLUS THERAPEUTICS, INC. | 2026-03-31 | 3/3 | $1.03M | -$6.95M | -$7.06M | — | -692.5% | 114 | 尚无授权文本 |
| TVA Texas Ventures Acquisition III Corp | 2026-03-31 | 3/3 | — | -$472,477 | — | — | — | 13 | 尚无授权文本 |
| TVAI Thayer Ventures Acquisition Corp II | 2026-03-31 | 3/3 | — | $993,698 | — | — | — | 7 | 尚无授权文本 |
| TVC Tennessee Valley Authority | 2026-03-31 | 3/3 | — | $392M | -$890M | — | — | 82 | 尚无授权文本 |
| TVE Tennessee Valley Authority | 2026-03-31 | 3/3 | — | $392M | -$890M | — | — | 82 | 尚无授权文本 |
| TVGN Tevogen Bio Holdings Inc. | 2026-03-31 | 3/3 | — | -$5.45M | — | — | — | 63 | 尚无授权文本 |
| TVRD Tvardi Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$6.8M | — | — | — | 106 | 尚无授权文本 |
| TVTX Travere Therapeutics, Inc. | 2026-03-31 | 3/3 | $127.2M | -$37.1M | — | 98.5% | -29.0% | 108 | 尚无授权文本 |
| VTVT vTv Therapeutics Inc. | 2026-03-31 | 3/3 | $36.84M | $24.13M | — | — | 63.1% | 112 | 尚无授权文本 |
| STVN Stevanato Group S.p.A. | 2025-12-31 | 2/3 | — | $139.83M | — | — | — | 102 | 尚无授权文本 |
| BVC BitVentures Ltd | 2025-06-30 | 3/3 | $0 | -$5.37M | -$6.48M | — | — | 50 | 尚无授权文本 |
| TV GRUPO TELEVISA, S.A.B. | 2024-12-31 | 2/3 | — | -$8.33B | — | — | — | 148 | 尚无授权文本 |
| ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | — | 0/3 | — | — | — | — | — | 5 | 尚无授权文本 |
| TVIV Texas Ventures Acquisition IV Corp | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |